OQRO

Feed News

Explore

Insider trades Fund holdings Congress trades Federal contracts

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

OQRO

Search/

Loading…

CFO received an award of 36K GILD derivative securities | OQRO

Insider trades

Insider trade

CFO received an award of 36K GILD derivative securities

Traded Mar 10, 2026 · Filed Mar 12, 2026

GILGilead SciencesGILD

36K
Derivative units

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Mar 10, 2026
Reporting period: Not applicable
Filed with the SEC: Mar 12, 2026

CFOGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001310204-26-000010
Filed / recorded

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Mar 12, 2026, 8:45 PM UTC

Added to OQRO

Oct 2, 2026, 12:27 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

GILEAD SCIENCES, INC.

Issuer CIK

882095

Ticker

GILD

Reporting person

Andrew D Dickinson

Relationship

Officer

Officer title

Chief Financial Officer

Security

Non-qualified Stock Option (Right to Buy)

Table

Derivative (Table II)

Transaction date

Mar 10, 2026

Transaction code

Shares / units

35,880

Price per share

$0.00

Acquired / disposed

Acquired (A)

Shares owned after

35,880

Ownership form

Direct

Amendment

Footnotes from the filing

The stock options have a four-year vesting schedule. 25% vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.

Around the same time

CEO sold ~$1.37M of Gilead Sciences

Scheduled in advance6mo ago

Officer sold ~$433K of Gilead Sciences

Scheduled in advance7mo ago

CFO sold ~$433K of Gilead Sciences

Scheduled in advance7mo ago